Skip to content

Author

Jia-Chen Xu

We have 3 of 100 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Therapeutic vaccines for NSCLC: From mechanisms to clinical translation

Despite advances in targeted therapy and immune checkpoint inhibitors (ICIs), durable disease control remains elusive for most patients with non-small cell lung cancer (NSCLC), particularly those with advanced-stage disease. Therapeutic cancer vaccines offer the potential for sustained immune surveillance by inducing t...

Wei-Jing Liu, Jie-Fei Han, K. Fei et al. · 4 citations
Sep 2026

Single-cell transcriptomics reveals a complex cell-cell communication network driven by myofibroblast-derived collagen in esophageal squamous cell carcinoma.

A high-resolution single-cell transcriptomic atlas of the ESCC tumor microenvironment is constructed via single-cell RNA sequencing of 15 tissue specimens derived from 8 ESCC patients, revealing Fibro_myo_C1 as a prominent fibroblast subset associated with ESCC progression that orchestrates stromal crosstalk to drive m...

Xiao-Wei Chen, Yuan-Yuan Lei, Da-Zhi Pang et al. · 0 citations
Open access Aug 2026

Genomic Profiling, Risk Stratification, and Post-Transformation Treatment Outcomes in Patients with Transformed Small-Cell Lung Cancer: A Multicenter Analysis.

Age, RB1/NTRK1 mutation, and secondary T790M mutation were identified as independent risk factors and integrated into a predictive model with high accuracy and establish a clinically applicable model for early prediction and risk stratification of SCLC transformation.

Ruolin Gao, Zhenxiang Li, Jie-Ying Huang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.